|
|
|
| DIA Oligonucleotide-Based Therapeutics Conference 2024 |
|
|
|
|
DIA Oligonucleotide-Based Therapeutics Conference 2024 |
Closed
|
| DIA/FDA Oligonucleotide-Based Therapeutics Conference |
| Dates:
Monday, October 28, 2024 - Wednesday, October 30, 2024
|
| Venue: Capital Hilton,
Washington DC,
United States |
|
|
The DIA Oligonucleotide-Based Therapeutics Conference brings together leading experts to inform, educate, and share advancements in oligonucleotide-based therapeutic product development. Developed collaboratively by regulators, industry professionals, and academics, the program covers a wide range of topics from the nonclinical, CMC, and clinical areas. The conference offers a unique experience with multiple perspectives presented, and the opportunity to interface with regulators from around the globe.
|
Website: https://www.diaglobal.org/en/conference-listing
|
|
|
|
|
